---
layout: post
title: "中国将来自印度的仿制药视为假药"
date: '2013-09-06T10:51:00.000+08:00'
author: Wenh Q
tags: 
modified_time: '2013-09-06T10:51:56.637+08:00'
blogger_id: tag:blogger.com,1999:blog-4961947611491238191.post-132341532901906815
blogger_orig_url: http://binaryware.blogspot.com/2013/09/blog-post_6.html
---

<div style="margin: 10px; padding: 5px;"><div style="font-size: 18px;"><a href="http://solidot.org.feedsportal.com/c/33236/f/556826/s/30d1b13b/sc/24/l/0L0Ssolidot0Borg0Cstory0Dsid0F36323/story01.htm"><br />中国将来自印度的仿制药视为假药</a>     </div><div style="font-size: 13px;">Via <a href="http://www.solidot.org/">Solidot</a>     </div></div><div style="font-size: 13px; padding: 15px 0 10px 10px;">《南方都市报》报导，在印度政府授权国内制药公司仿制受专利保护的抗癌药物之后，印度的仿制抗癌药费用只是专利药品的几十分之一，让普通人也能承担的起。而中国的专利抗癌药物同样非常居高不下令人生畏——例如诺华公司的白血病治疗药物格列卫一盒售价2.5万元左右，而印度仿制药仅仅为1300元左右，即使能报销90%，还是印度药便宜，因此有些人利用现成的渠道（如有亲人在印度工作）代购廉价的印度仿制药。但这些没有批文的仿制药被视为假药扣押，相关代购人士也遭到逮捕。药监部门工作人员称，在互联网从事药品经营需要取得《药品经营许可证》及《互联网药品交易服务机构资格证书》。而根据《药品经营许可证》申请条文，普通人不可能拥有申请资格。<img border="0" src="http://solidot.org.feedsportal.com/c/33236/f/556826/s/30d1   b13b/sc/24/mf.gif" height="1" width="1" /><br /><div><table border="0"><tbody><tr><td valign="middle"><a href="http://share.feedsportal.com/share/twitter/?u=http%3A%2F%2Fwww.solidot.org%2Fstory%3Fsid%3D36323&amp;t=%E4%B8%AD%E5%9B%BD%E5%B0%86%E6%9D%A5%E8%87%AA%E5%8D%B0%E5%BA%A6%E7%9A%84%E4%BB%BF%E5%88%B6%E8%8D%AF%E8%A7%86%E4%B8%BA%E5%81%87%E8%8D%AF" target="_blank"><img border="0" src="http://res3.feedsportal.com/social/twitter.png" /></a>&nbsp;<a href="http://share.feedsportal.com/share/facebook/?u=http%3A%2F%2Fwww.solidot.org%2Fstory%3Fsid%3D36323&amp;t=%E4%B8%AD%E5%9B%BD%E5%B0%86%E6%9D%A5%E8%87%AA%E5%8D%B0%E5%BA%A6%E7%9A%84%E4%BB%BF%E5%88%B6%E8%8D%AF%E8%A7%86%E4%B8%BA%E5%81%87%E8%8D%AF" target="_blank"><img border="0" src="http://res3.feedsportal.com/social/facebook.png" /></a>&nbsp;<a href="http://share.feedsportal.com/share/linkedin/?u=http%3A%2F%2Fwww.solidot.org%2Fstory%3Fsid%3D36323&amp;t=%E4%B8%AD%E5%9B%BD%E5%B0%86%E6%9D%A5%E8%87%AA%E5%8D%B0%E5%BA%A6%E7%9A%84%E4%BB%BF%E5%88%B6%E8%8D%AF%E8%A7%86%E4%B%20%20%208%BA%E5%81%87%E8%8D%AF" target="_blank"><img border="0" src="http://res3.feedsportal.com/social/linkedin.png" /></a>&nbsp;<a href="http://share.feedsportal.com/share/gplus/?u=http%3A%2F%2Fwww.solidot.org%2Fstory%3Fsid%3D36323&amp;t=%E4%B8%AD%E5%9B%BD%E5%B0%86%E6%9D%A5%E8%87%AA%E5%8D%B0%E5%BA%A6%E7%9A%84%E4%BB%BF%E5%88%B6%E8%8D%AF%E8%A7%86%E4%B8%BA%E5%81%87%E8%8D%AF" target="_blank"><img border="0" src="http://res3.feedsportal.com/social/googleplus.png" /></a>&nbsp;<a href="http://share.feedsportal.com/share/email/?u=http%3A%2F%2Fwww.solidot.org%2Fstory%3Fsid%3D36323&amp;t=%E4%B8%AD%E5%9B%BD%E5%B0%86%E6%9D%A5%E8%87%AA%E5%8D%B0%E5%BA%A6%E7%9A%84%E4%BB%BF%E5%88%B6%E8%8D%AF%E8%A7%86%E4%B8%BA%E5%81%87%E8%8D%AF" target="_blank"><img border="0" src="http://res3.feedsportal.com/social/email.png" /></a></td><td valign="middle"></td></tr></tbody></table></div><br /><br /><a href="http://da.feedsportal.com/r/173608355066/u/49/f/556826/c/33236/s/30d1b13b/a2.htm"><img border="0" src="http://da.feedsportal.com/r/173608355066/u/49/f/   556826/c/33236/s/30d1b13b/a2.img" /></a><img border="0" src="http://pi.feedsportal.com/r/173608355066/u/49/f/556826/c/33236/s/30d1b13b/a2t.img" height="1" width="1" /><br /><div><a href="http://feeds.feedburner.com/~ff/solidot?a=lFF6NrbCOkI:kh5cF75x6rU:yIl2AUoC8zA"><img border="0" src="http://feeds.feedburner.com/~ff/solidot?d=yIl2AUoC8zA" /></a> <a href="http://feeds.feedburner.com/~ff/solidot?a=lFF6NrbCOkI:kh5cF75x6rU:7Q72WNTAKBA"><img border="0" src="http://feeds.feedburner.com/~ff/solidot?d=7Q72WNTAKBA" /></a></div></div>